BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that John C. Wright, 59, has been appointed to Sucampo Pharmaceuticals’ Board of Directors. Wright was a partner of Ernst & Young, LLP, where he served for nearly 30 years until his retirement in 2000. He becomes the sixth independent member of Sucampo Pharmaceuticals’ seven-member Board. Wright will also serve on the Audit Committee.
